Increased infection risk in patients on preventive CGRP-targeting therapies– a meta-analysis and clinical effect assessment by Marcin Straburzyński, Daria Kopyt, Karol Marschollek, Bartłomiej Błaszczyk, Ewa Kuca-Warnawin, Weronika Kurowska, Błażej Misiak, Kuan-Po Peng, Marta Waliszewska-Prosół, Arne May

Subjects: Get full text

Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: post hoc analysis of the DELIVER trial by Piero Barbanti, Susanne F. Awad, Heather Rae-Espinoza, Stephane A. Regnier, Xin Ying Lee, Peter J. Goadsby

Subjects: Get full text

Comprehensive safety analysis of adverse events associated with eptinezumab in migraine treatment by Junchen Chen, Shunqiu Huang, Yashi Chen, Cheng Luo, Yong Li

Subjects: “…Eptinezumab…”
Get full text

In the era of monoclonal antibodies targeting the calcitonin gene-related peptide pathway, is it still necessary to stop taking excessive pain medication? by Renata Gomes Londero

Subjects: Get full text

Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study by Damiana Scuteri, Martina Pagliaro, Rosario Iannacchero, Michele Trimboli, Gary W. Lawrence, Giacinto Bagetta, Maria Tiziana Corasaniti

Subjects: “…Eptinezumab…”
Get full text

Safety, efficacy, and compliance of moderate-to-high dose eptinezumab and erenumab in chronic migraine patients with medication-overuse headache: an updated systematic review and m... by Nhan Nguyen, Vinh Ho Quang Tri, Vy Nguyen Ngoc Dan, Nghi Bao Tran, Laszlo Olah, Mate Heja

Subjects: Get full text

Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcan... by Davor Jančuljak, Damir Petravić, Darija Mahović Lakušić, Arijana Lovrenčić-Huzjan, Koraljka Bačić Baronica, Marijana Bosnar Puretić, Zlatko Hucika, Marina Titlić, Zvonimir Popović, Zoran Tomić, Maristela Stojić, Vanja Bašić Kes

Subjects: Get full text